Peer-reviewed journal articles (260)
99.
Saussez, S., Decaestecker, C., Cludts, S., Ernoux-Neufcoeur, P., Chevalier, D., Smetana Jr., K., André, S., Leroy, X., & Gabius, H.-J. (2009). Adhesion/growth-regulatory tissue lectin galectin-1 in relation to angiogenesis/lymphocyte infiltration and prognostic relevance of stromal up-regulation in laryngeal carcinomas. Anticancer research, 29(1), 59-65.100.
Yen, L., Fouss, F., Decaestecker, C., Francq, P., & Saerens, M. (2009). Graph nodes clustering with the sigmoid commute-time kernel: a comparative study. Data & knowledge engineering, 68(3), 338-361.101.
Mathieu, A., Nagy, N., Decaestecker, C., Ferdinande, L., Vandenbroucke, K., Rottiers, P., Cuvelier, C. A., Salmon, I., & Demetter, P. (2008). Expression of galectins-1, -3 and -4 varies with strain and type of experimental colitis in mice. International journal of experimental pathology, 89(6), 438-446. doi:10.1111/j.1365-2613.2008.00598.x102.
Rorive, S., Berton, A., D'Haene, N., Takacs, C. N., Debeir, O., Decaestecker, C., & Salmon, I. (2008). Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas. GLIA, 56(15), 1679-1690. doi:10.1002/glia.20719103.
Capouillez, A., Decaestecker, C., Filleul, O., Chevalier, D., Coppee, F., Leroy, X., Belayew, A., & Saussez, S. (2008). Helicase-like transcription factor exhibits increased expression and altered intracellular distribution during tumor progression in hypopharyngeal and laryngeal squamous cell carcinomas. Virchows Archiv, 453(5), 491-499. doi:10.1007/s00428-008-0675-9104.
Debeir, O., Megalizzi, V., Warzée, N., Kiss, R., & Decaestecker, C. (2008). Videomicroscopic extraction of specific information on cell proliferation and migration in vitro. Experimental cell research, 314(16), 2985-2998. doi:10.1016/j.yexcr.2008.06.010105.
Saussez, S., Decaestecker, C., Mahillon, V., Cludts, S., Capouillez, A., Chevalier, D., Vet, H. K., André, S., Toubeau, G., Leroy, X., & Gabius, H.-J. (2008). Galectin-3 upregulation during tumor progression in head and neck cancer. The Laryngoscope, 118(9), 1583-1590. doi:10.1097/MLG.0b013e31817b0718106.
Dumont, P., Berton, A., Nagy, N., Sandras, F., Tinton, S., Demetter, P., Mascart, F., Allaoui, A., Decaestecker, C., & Salmon, I. (2008). Expression of galectin-3 in the tumor immune response in colon cancer. Laboratory investigation, 88(8), 896-906. doi:10.1038/labinvest.2008.54107.
Pozdzik, A., Salmon, I., Husson, C., Decaestecker, C., Rogier, E., Bourgeade, M.-F., Deschodt Lanckman, M., Vanherweghem, J.-L., & Nortier, J. (2008). Patterns of interstitial inflammation during the evolution of renal injury in experimental aristolochic acid nephropathy. Nephrology, dialysis, transplantation, 23(8), 2480-2491. doi:10.1093/ndt/gfn140108.
Mijatovic, T., Mahieu, T., Bruyère, C., De Nève, N., Dewelle, J., Simon, G., Dehoux, M., van der Aar, E., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Van Quaquebeke, E., Darro, F., & Kiss, R. (2008). UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. Neoplasia (New York, N.Y.), 10(6), 573-586. doi:10.1593/neo.08290109.
Le Mercier, M., Lefranc, F., Mijatovic, T., Debeir, O., Haibe-Kains, B., Bontempi, G., Decaestecker, C., Kiss, R., & Mathieu, V. (2008). Evidence of galectin-1 involvement in glioma chemoresistance. Toxicology and applied pharmacology, 229(2), 172-183. doi:10.1016/j.taap.2008.01.009110.
Maris, C., Rorive, S., Sandras, F., D'Haene, N., Sadeghi-Meibodi, N., Bièche, I., Vidaud, M., Decaestecker, C., & Salmon, I. (2008). Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas. Neuropathology and applied neurobiology, 34(3), 316-329. doi:10.1111/j.1365-2990.2007.00898.x111.
Mijatovic, T., De Nève, N., Gailly, P., Mathieu, V., Haibe-Kains, B., Bontempi, G., Lapeira, J., Decaestecker, C., Facchini, V., & Kiss, R. (2008). Nucleolus and c-Myc: potential targets of cardenolide-mediated antitumor activity. Molecular cancer therapeutics, 7(5), 1285-1296. doi:10.1158/1535-7163.MCT-07-2241112.
Le Mercier, M., Mathieu, V., Haibe-Kains, B., Bontempi, G., Mijatovic, T., Decaestecker, C., Kiss, R., & Lefranc, F. (2008). Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses. Journal of neuropathology and experimental neurology, 67(5), 456-469. doi:10.1097/NEN.0b013e318170f892113.
Demetter, P., Nagy, N., Martin, B., Mathieu, A., Dumont, P., Decaestecker, C., & Salmon, I. (2008). The galectin family and digestive disease. Journal of pathology, 215(1), 1-12. doi:10.1002/path.2334114.
Sadeghi-Meibodi, N., D'Haene, N., Decaestecker, C., Levivier, M., Metens, T., Maris, C., Wikler, D., Balériaux, D., Salmon, I., & Goldman, S. (2008). Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. American journal of neuroradiology, 29(3), 476-482. doi:10.3174/ajnr.A0851115.
Saussez, S., Decaestecker, C., Lorfevre, F., Chevalier, D., Mortuaire, G., Kaltner, H., André, S., Toubeau, G., Gabius, H.-J., & Leroy, X. (2008). Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology, 52(4), 483-493. doi:10.1111/j.1365-2559.2008.02973.x116.
Pozdzik, A., Salmon, I., Debelle, F., Decaestecker, C., Van den Branden, C., Verbeelen, D., Deschodt Lanckman, M., Vanherweghem, J.-L., & Nortier, J. (2008). Aristolochic acid induces proximal tubule apoptosis and epithelial to mesenchymal transformation. Kidney international, 73(5), 595-607. doi:10.1038/sj.ki.5002714117.
Lemy, A., Wissing, K. M., Rorive, S., Zlotta, A., Roumeguere, T., Muniz Martinez, M. C., Decaestecker, C., Salmon, I., Abramowicz, D., Vanherweghem, J.-L., & Nortier, J. (2008). Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: a case series with 15-year follow-up. American journal of kidney diseases, 51(3), 471-477. doi:10.1053/j.ajkd.2007.11.015118.
D'Haene, N., Catteau, X., Maris, C., Martin, B., Salmon, I., & Decaestecker, C. (2008). Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas. British journal of haematology, 140(4), 402-410. doi:10.1111/j.1365-2141.2007.06929.x